2023_RDD_Europe_May_Antibes_Skyscraper

advanced search

Pulmonary & Nasal Drug Delivery50

Issue No #50  June 19th, 2014


Download PDF


Inside the magazine

FORMULATION METHODS & SIZE REDUCTION FOR INHALERS
PULMONARY
Bert Dekens
Hosokawa Micron BV
FORMULATION METHODS & SIZE REDUCTION FOR INHALERS
Bert Dekens highlights the importance of achieving the correct particle sizes, both for the API and the carrier in formulations for inhalation, and describes some of the available equipment most suited to specific tasks.
THE eFLOW “CLOSED SYSTEM”
PULMONARY
Thomas Gallem
PARI
THE eFLOW “CLOSED SYSTEM”
Thomas Gallem describes the design and development stages, including the incorporation of human-factors engineering and optimisation for elderly patients, of the company’s eFlow CS nebuliser, which uses a proprietary single-dose drug ampoule as an integral part of the nebuliser handset.
GENERIC PMDI PRODUCT DEVELOPMENT FOR THE US: KEY CONSIDERATIONS
PULMONARY
Badre Hammond
Next Breath
GENERIC PMDI PRODUCT DEVELOPMENT FOR THE US: KEY CONSIDERATIONS
Badre Hammond highlights key considerations and addresses strategies that are believed to reduce risk and ultimately speed up the process for getting a generic pMDI product to the US market.
ARTIFICIAL NEURAL NETWORKS & TISSUE MODELS
PULMONARY
Prof Marc Brown
MedPharm
ARTIFICIAL NEURAL NETWORKS & TISSUE MODELS
Marc Brown, Jo Muddle and Professor Clive Page describe the use of artificial neural networks and novel tissue models as methods for formulation candidate screening, selection and characterisation and, in generic product development, for bioequivalence testing.
SCALE-UP & QBD APPROACHES FOR SPRAY-DRIED INHALATION FORMULATIONS
PULMONARY
Dr Eunice Costa
Hovione
SCALE-UP & QBD APPROACHES FOR SPRAY-DRIED INHALATION FORMULATIONS
Eunice Costa, Filipe Neves, Gonçalo Andrade and Conrad Winters describe the strong position of inhalable products in preclinical and clinical pipelines and make the case for formulation-based approaches to enable and enhance pulmonary product development. Spray-drying technology in particular is highlighted as a highly favourable, scalable manufacturing technique for inhalable composite particles.
SCOPING THE DESIGN SPACE FOR GENERIC NASAL SPRAYS
NASAL
Dr Deborah Huck-Jones
Malvern Panalytical
SCOPING THE DESIGN SPACE FOR GENERIC NASAL SPRAYS
Deborah Huck-Jones and Paul Kippax discuss analytical methods that can be helpful for demonstrating bioequivalence in the development of generic nasal sprays.
RESPIRATORY DRUG DELIVERY (RDD) 2014
CONFERENCE REVIEW
RESPIRATORY DRUG DELIVERY (RDD) 2014
Respiratory Drug Delivery® celebrated its 25th Anniversary at the El Conquistador Resort in Fajardo, Puerto Rico, from May 4 to May 8, 2014.
Top